Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Maintains Buy on APi Gr, Raises Price Target to $24

Citigroup analyst Andrew Kaplowitz maintains APi Gr (NYSE:APG) with a Buy and raises the price target from $21 to $24.

byBenzinga Newsdesk

December 9, 2022

1 minute read

Citigroup analyst Andrew Kaplowitz maintains APi Gr (NYSE:APG) with a Buy and raises the price target from $21 to $24.

Stellantis Inks Battery Materials Supply Deal With Element 25; Plans To Make Equity Investment

By Shivani Kumaresan

Today, 2:17 AM

Stellantis NV (NYSE:STLA) has signed an agreement for Element 25 to supply battery-grade, high-purity manganese sulphate monohydrate for use in…

STLA

The Rivian IPO: What You Need To Know

By Shanthi Rexaline

Today, 2:17 AM

Electric vehicle maker Rivian Automotive, Inc. (NASDAQ: RIVN) is all set to list its shares on Wall Street this week, having amended on Friday the Form S-1 statement originally filed on Oct. 1.

AMZN

Stifel Maintains Hold on Willis Towers Watson, Raises Price Target to $255

By Benzinga Newsdesk

Today, 2:17 AM

Stifel analyst Shlomo Rosenbaum maintains Willis Towers Watson (NASDAQ:WTW) with a Hold and raises the price target from $228 to $255.

WTW

Bellerophon Therapeutics Q2 EPS $(0.36) Up From $(0.51) YoY

By Benzinga Newsdesk

Today, 2:17 AM

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.36) per share. This is a 29.41 percent increase over losses of $(0.51) per share from the same period last year.

BLPH

Citigroup Maintains Buy on APi Gr, Raises Price Target to $24

Related Posts

Stellantis Inks Battery Materials Supply Deal With Element 25; Plans To Make Equity Investment

The Rivian IPO: What You Need To Know

Stifel Maintains Hold on Willis Towers Watson, Raises Price Target to $255

Bellerophon Therapeutics Q2 EPS $(0.36) Up From $(0.51) YoY